Drug maker to cut jobs in Norman
NORMAN — Astellas Pharma Technologies Inc. is offering early retirement and a "voluntary termination plan” to its Norman work force of 200 as part of a restructuring in advance of the expiration of a key drug patent.
Astellas anticipates the expiration of the Flomax drug patent will reduce the production volume at the plant and hopes that up to 60 workers in Norman will take the early retirement option, spoke...
You have selected to view an article that is older than 60 days. There are several ways to unlock access to NewsOK historical content.
Please sign in. (You might already have access)
If you are a print subscriber to The Oklahoman, activate your Digital Pass for free access.
Purchase any of The Oklahoman's digital products (digital replica, archives, iPad and smartphone apps), and access to historical NewsOK content is free.
Please sign in. (You might already have access)
If you are a print subscriber to The Oklahoman, activate your Digital Pass for free access.
Purchase any of The Oklahoman's digital products (digital replica, archives, iPad and smartphone apps), and access to historical NewsOK content is free.
